학술논문

REDUX: A MULTICENTER, OPEN-LABEL STUDY OF DM199 (RECOMBINANT HUMAN TISSUE KALLIKREIN-1) IN PATIENTS WITH STAGE II OR III CHRONIC KIDNEY DISEASE
Document Type
Journal
Source
AMERICAN JOURNAL OF KIDNEY DISEASES; APR 2021, 77 4, p571-p571, 1p.
Subject
Language
English
ISSN
15236838